Expanding the Efficacy of Project UPLIFT: Distance Delivery of Mindfulness-Based Depression Prevention to People With Epilepsy

被引:89
|
作者
Thompson, Nancy J. [1 ]
Patel, Archna H. [1 ]
Selwa, Linda M. [2 ]
Stoll, Shelley C. [3 ]
Begley, Charles E.
Johnson, Erica K. [4 ]
Fraser, Robert T. [4 ]
机构
[1] Emory Univ, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA
[2] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Ctr Managing Chron Dis, Ann Arbor, MI 48109 USA
[4] Univ Washington, Dept Neurol, Vocat Serv Unit, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
major depressive disorder; mindfulness-based cognitive therapy; Internet; telephone; epilepsy; MAJOR DEPRESSION; PRIME-MD; DISORDERS; VALIDITY; COMORBIDITY; RELIABILITY; PREVALENCE; VALIDATION; SEVERITY; THERAPY;
D O I
10.1037/a0038404
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: Depression affects about 16% of the U.S. population over a lifetime. People with chronic diseases have especially high rates of comorbid depression; 32% to 48% of people with epilepsy experience depression. This study evaluated the efficacy of a mindfulness-based cognitive therapy intervention for preventing major depressive disorder (MDD) episodes in people with epilepsy. Method: Participants (n = 128) were adults from Georgia, Michigan, Texas, and Washington with epilepsy and mild/moderate depressive symptoms. The 8-session weekly Project UPLIFT intervention, based on mindfulness-based cognitive therapy, was group-delivered via Web or telephone. Using a randomized, controlled crossover design, participants were assigned to Project UPLIFT or a treatment-as-usual (TAU) waitlist and assessed at baseline, and after intervening in the intervention group (similar to 10 weeks) and in the TAU group (similar to 20 weeks). Assessments included valid self-report measures of depression and MDD, knowledge/skills, and satisfaction with life. Results: The incidence of MDD episodes (new or relapse) from baseline to interim assessment was significantly lower in the intervention condition (0.0%) than in TAU (10.7%). Depressive symptoms decreased significantly more in the intervention condition than in TAU; Web and telephone did not differ. Change in knowledge/skills mediated the effect, which persisted over the 10 weeks of follow-up. Knowledge/skills and life satisfaction increased significantly more in the intervention condition than in TAU. Conclusions: Distance delivery of group mindfulness-based cognitive therapy can prevent episodes of MDD, reduce symptoms of depression, and increase life satisfaction in people with epilepsy. This intervention is easily modified for persons with other chronic diseases and other disparity populations.
引用
收藏
页码:304 / 313
页数:10
相关论文
共 43 条
  • [31] The DARE study of relapse prevention in depression: design for a phase 1/2 translational randomised controlled trial involving mindfulness-based cognitive therapy and supported self monitoring
    Shawyer, Frances
    Meadows, Graham N.
    Judd, Fiona
    Martin, Paul R.
    Segal, Zindel
    Piterman, Leon
    BMC PSYCHIATRY, 2012, 12
  • [32] The Development and Internal Evaluation of a Predictive Model to Identify for Whom Mindfulness-Based Cognitive Therapy Offers Superior Relapse Prevention for Recurrent Depression Versus Maintenance Antidepressant Medication
    Cohen, Zachary D.
    DeRubeis, Robert J.
    Hayes, Rachel
    Watkins, Edward R.
    Lewis, Glyn
    Byng, Richard
    Byford, Sarah
    Crane, Catherine
    Kuyken, Willem
    Dalgleish, Tim
    Schweizer, Susanne
    CLINICAL PSYCHOLOGICAL SCIENCE, 2023, 11 (01) : 59 - 76
  • [33] Digital Characteristics and Dissemination Indicators to Optimize Delivery of Internet-Supported Mindfulness-Based Interventions for People With a Chronic Condition: Systematic Review
    Russell, Lahiru
    Ugalde, Anna
    Milne, Donna
    Austin, David
    Livingston, Patricia M.
    JMIR MENTAL HEALTH, 2018, 5 (03):
  • [34] Changes in Attentional Processing of Emotional Information Following Mindfulness-Based Cognitive Therapy in People with a History of Depression: Towards an Open Attention for all Emotional Experiences
    Rudi De Raedt
    Saskia Baert
    Ineke Demeyer
    Ellen Goeleven
    An Raes
    Adriaan Visser
    Michel Wysmans
    Erik Jansen
    Rik Schacht
    Joël R. Van Aalderen
    Anne Speckens
    Cognitive Therapy and Research, 2012, 36 : 612 - 620
  • [35] Changes in Attentional Processing of Emotional Information Following Mindfulness-Based Cognitive Therapy in People with a History of Depression: Towards an Open Attention for all Emotional Experiences
    De Raedt, Rudi
    Baert, Saskia
    Demeyer, Ineke
    Goeleven, Ellen
    Raes, An
    Visser, Adriaan
    Wysmans, Michel
    Jansen, Erik
    Schacht, Rik
    Van Aalderen, Joel R.
    Speckens, Anne
    COGNITIVE THERAPY AND RESEARCH, 2012, 36 (06) : 612 - 620
  • [36] A comparison of the efficacy of mindfulness-based cognitive therapy and Beck cognitive therapy on the depression and anxiety of patients recovering from COVID-19: A pilot study
    Khajehnezhad, Maryam
    Veshki, Sahar Khanjani
    COUNSELLING & PSYCHOTHERAPY RESEARCH, 2024, 24 (04) : 1649 - 1659
  • [37] Effectiveness Evaluation of Repetitive Transcranial Magnetic Stimulation Therapy Combined with Mindfulness-Based Stress Reduction for People with Post-Stroke Depression: A Randomized Controlled Trial
    Duan, Haoran
    Yan, Xin
    Meng, Shifeng
    Qiu, Lixia
    Zhang, Jiayu
    Yang, Chunxia
    Liu, Sha
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2023, 20 (02)
  • [38] The DARE study of relapse prevention in depression: design for a phase 1/2 translational randomised controlled trial involving mindfulness-based cognitive therapy and supported self monitoring
    Frances Shawyer
    Graham N Meadows
    Fiona Judd
    Paul R Martin
    Zindel Segal
    Leon Piterman
    BMC Psychiatry, 12
  • [39] The Development and Internal Evaluation of a Predictive Model to Identify for Whom Mindfulness-Based Cognitive Therapy Offers Superior Relapse Prevention for Recurrent Depression Versus Maintenance Antidepressant Medication
    Cohen, Zachary
    DeRubeis, Robert
    Hayes, Rachel
    Watkins, Edward
    Lewis, Glyn
    Byng, Richard
    Byford, Sarah
    Crane, Catherine
    Kuyken, Willem
    Dalgleish, Tim
    Schweizer, Susanne
    BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S36 - S37